06/04/2026
Please join us in welcoming Andy Kilianski, Ph.D., to QBI as our new Chief Science and Technology Officer.
Andy brings more than a decade of experience spanning virology, national security, and translational research leadership. As QBI continues to expand its technology platforms and translational efforts, he’ll help connect our science with new opportunities in biotechnology, AI-driven discovery, and therapeutic development.
We’re excited for what’s ahead. Welcome, Andy!
Read the full announcement: link in bio.